TAXOTERE for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TAXOTERE was used for Lung neoplasm malignant.
Most Reported Side Effects for TAXOTERE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 22 | 9.8% | 3 | 14 |
| Nausea | 21 | 9.3% | 1 | 14 |
| Dyspnoea | 18 | 8.0% | 3 | 10 |
| Disease progression | 15 | 6.7% | 4 | 2 |
| Febrile neutropenia | 13 | 5.8% | 2 | 11 |
| Mucosal inflammation | 13 | 5.8% | 1 | 4 |
| Pyrexia | 13 | 5.8% | 2 | 10 |
| Neutropenia | 12 | 5.3% | 2 | 8 |
| Asthenia | 10 | 4.4% | 1 | 5 |
| Pleural effusion | 10 | 4.4% | 4 | 4 |
| Rash | 10 | 4.4% | 1 | 4 |
| Thrombocytopenia | 10 | 4.4% | 1 | 8 |
| Erythema | 9 | 4.0% | 1 | 2 |
| Neuropathy peripheral | 9 | 4.0% | 0 | 3 |
| Vomiting | 9 | 4.0% | 1 | 7 |
Other Indications for TAXOTERE
Breast cancer (54)
Product used for unknown indication (40)
Breast cancer metastatic (18)
Prostate cancer (12)
Chemotherapy (11)
Invasive ductal breast carcinoma (7)
Non-small cell lung cancer (6)
Prostate cancer metastatic (5)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)